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Pulmonary nocardiosis (PN) is a rare but severe disease caused by Nocardia spp. Despite the traditional
description as opportunistic infection, case reports and case series of pulmonary nocardiosis have
recently been reported in immunocompetent patients too, in particular among people with chronic
pulmonary diseases such as advanced Chronic Obstructive Pulmonary Disease (COPD).
PN is characterized by non-speciﬁc symptoms and radiological ﬁndings; bacteriological culture can be
difﬁcult. For the reasons above, diagnosis of PN is challenging, sometimes resulting in a misdiagnosis of
tuberculosis.
We report an interesting case of PN in a 75-year-old male with COPD. He complained a 3-months
history of fatigue, evening rise in body temperature, night sweats, unexplained weight loss of 5 kg,
worsening dyspnea, cough and mucopurulent sputum. The chest X-ray showed multiple nodules with
cavitations bilaterally in the apical and subclavian regions. Nocardia cyriacigeorgica with 100% identity
was identiﬁed in three sputum samples.
Since the patient has never undergone a systemic and/or inhaled steroid therapy, and has no respi-
ratory failure and comorbidities entailing immunodepression, it is conceivable that, in this immuno-
competent patient, the COPD could represent an isolated risk factor for PN.
Risk factors, clinical presentations, radiographic ﬁndings, differential diagnosis and review of the
literature of PN cases in COPD, pointing out the similarities and differences, are also described.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pulmonary nocardiosis (PN) is a rare but severe opportunistic
infectious disease caused by Nocardia spp. The microorganism was
ﬁrst isolated by Edmond Nocard in 1888 from cattle with bovine
farcy [1]; Eppinger reported the ﬁrst human case of nocardiosis in
1890 [2]. The bacteria is commonly found in long standing dust, soilsease, COPD; Human Immu-
mography, HRCT; Pulmonary
methoxazole, TMP-SMX.
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stellana).
Ltd. This is an open access article uand stagnant water. Aerosol route is the main portal of entry into
the body; direct inoculation as result of trauma or intravenous drug
assumption or, more rarely, ingestion of contaminated food have
also been described [3]. Human-to-human transmission has not
been documented [4,5].
The prevalence of PN is not known. Traditionally, PN has been
described in immunocompromised patients, with human immu-
nodeﬁciency virus (HIV) infection, alcohol abuse, diabetes mellitus,
organ transplantation and lymphoreticular neoplasm as the most
frequently associated conditions [4,5]; lung transplant patients
have the highest frequency of PN among recipients of solid organs
[6]. Iatrogenic immunosuppression is a further risk factor, with
long-term steroid, chemotherapeutic immunosuppressive and anti
TNF-a agents as the most commonly associated drugs [4e8]; in
particular, chronic steroid therapy has been highlighted in 36% [8],nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Chest X-ray showing sclerosis and multiple nodules with cavitations in upper
and medium lung zones bilaterally.
Fig. 2. Chest HRCT scan showing multiple nodular lesions with cavitations in upper
lung zone bilaterally.
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drug abuse has also been described [10].
Commonly, PN presents as a subacute or chronic disease, with a
marked tendency towards remissions and exacerbations. It is
characterized by non-speciﬁc symptoms such as low fever, night
sweats, weight loss, cough, expectoration, dyspnea and chest pain;
radiological ﬁndings include areas of consolidation, nodules and
cavitations which are not pathognomonic [4]. Bacteriological cul-
ture can be problematic too. Therefore the clinical and imaging
presentation can be very similar to tuberculosis (TB) which repre-
sents one of the differential diagnosis [11,12]. Mortality is very high,
ranging from 14 to 40% and increasing to 60e100% in patients with
dissemination to the central nervous system [5,13]. Life-saving
treatments are widely available: trimethoprim-sulfamethoxazole
(TMP-SMX) is often used alone, but combination therapy is rec-
ommended and should continue until clinical patient improvement
occurs and Nocardia species identiﬁcation and antimicrobial drug
susceptibility information can be conﬁrmed; single-drug therapy
may sufﬁce thereafter [14].
In recent years, nocardiosis has been described among immu-
nocompetent patients, both as isolated cases and case series, in
lungs and other sites [15e20]. They can represent from 33% to 56%
of total cases [21,22]. In particular, among patients with chronic
respiratory diseases, Chronic Obstructive Pulmonary Disease
(COPD) and bronchiectasis have been found as predisposing factors
[23e39]. Despite reports in literature are limited, COPD is consid-
ered the third most common risk factor, surpassed only by chronic
steroid treatment and solid organ transplantation [4,33,40e42].
Moreover, COPD life expectancy can be strongly affected by
PN: a mortality rate of 17% within the ﬁrst month and 33% within
the ﬁrst year from diagnosis of PN have been reported [42].
In comparison, the mortality rate for acute exacerbation of
COPD is 8% during hospital stay and 23% after 1 year of
follow-up [43].
Here we present a case of PN mimicking TB in a patient with
undiagnosed COPD.
2. Case presentation
A 75-year-old white male, weighing 65 kg, presented to our
center with complaints of a 3-months history of fatigue, evening
rise in body temperature, night sweats, unexplained weight loss of
5 kg, worsening dyspnea, cough andmucopurulent sputum. Hewas
a current smoker (30 pack/years) and worked in a stone quarry up
to 12 years before; he had a history of chronic catarrhal bronchitis,
benign prostatic hypertrophy and an intestinal polypectomy. He
denied performing spirometry and taking systemic or inhaled
corticosteroids; a chest x-ray of 3 years before showed rarefaction
of bronchovascular tree.
On examination, he was afebrile and reduced vesicular murmur
and widespread rhonchi were heard on auscultation of the chest.
Remainder of the physical examination was unremarkable.
Blood tests showed neutrophilic leukocytosis (white blood cells
16500/mL, 70% neutrophils), mild anemia (hemoglobin 11,4 g/dl),
moderate increase in serum inﬂammatory markers (erythrocyte
sedimentation rate 72 mm/h, C-reactive protein 20 mg/l). Plasma
immunoglobulin, liver and renal functionwere in the normal range
and HIV antibody testing was negative.
A spirometry test was performed, revealing a severe obstructive
ventilation defect, post b2 agonist Forced Vital Capacity of 72% and
Forced Expiratory Volume in one second of 46% predicted. The
chest X-ray showed, bilaterally in the apical and subclavian regions,
sclerosis and multiple nodules with cavitations (Fig. 1). The chest
high resolution computed tomography (HRCT) was reported as
following: “Multiple nodular opacities are recognized in the upperlobes, in the apical segments of the lower lobes and in subpleural
location; small and regular central cavitations are there in some of
these lesions. Multiple focal points of “tree in bud” and bronchi-
ectasis, with prevalent cystic type, in both lung apices are also
present. No signiﬁcant mediastinal lymphadenopathy. These ﬁnd-
ings are consistent with chronic TB” (Fig. 2).
Three sputum samples on three different days were collected
and submitted for the search of Mycobacteria spp. Specimen were
digested and decontaminated according to Kubica procedure;
sputum smears for acid-fast bacilli examination using Kinyoun
staining and culture on solid (L€owensteineJensen) and liquid
medium (Mycobacteria Growth Indicator Tube) were then pre-
pared. The microscopic examination showed ﬁlamentous, slim,
branched (mycelium and hyphae), blue-to-fuchsia colored (acid-
alcohol variable) elements (Fig. 3). Nocardia spp. was suspected
and conﬁrmed by Gram staining (not shown) and blood agar
culture (Fig. 4). Culture on L€owensteineJensen medium is
showed in Fig. 5. All the previous exams were negative for M.
tuberculosis.
Fig. 3. Kinyoun-stained sputum sample showing ﬁlamentous, slim, branched (myce-
lium and hyphae), blue-to-fuchsia colored (acid-alcohol variable) elements.
Fig. 4. Sputum culture on blood agar showing wrinkled chalky white or cream-to-pink
colored colonies.
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sequencing of a DNA fragment coding a rRNA 16S (Applied Bio-
system, USA). Sequences were compared with the reference ones
present in the GenBank database through BLAST and NocardiaFig. 5. Sputum culture on Lowenstein-Jensen showing wet salmon-to-yellow colored
colonies.cyriacigeorgica with 100% identity was identiﬁed.
Minimal inhibitory concentrations were determined on Mueller
Hinton Agar following a 24 h incubation at 37 C (Etest, Bio-
Merieux). Results were revised and interpreted according to CLSI
criteria: amikacin 0.25 mg/mL; amoxicillin plus clavulanic acid
(8 mg/mL); ceftriaxone (1 mg/mL); cefepime (2 mg/mL); ciproﬂoxacin
(4 mg/mL); clarythromycin (4 mg/mL); imipenem (0.38 mg/mL);
linezolid (0.50 mg/mL); tobramycin (0.047 mg/mL); trimethoprim
plus sulfonamide (0.006 mg/mL).
Patient was then started on trimethoprim-sulfamethoxazole
(160/800 one tablet twice per day) for 6 months. Following this, a
rapid improvement of symptoms, regression of the purulent
sputum and of the neutrophilic leukocytosis had been achieved. A
second chest radiograph was performed 2 months later, showing
an improvement of radiological ﬁndings too. A spirometry test was
then repeated, conﬁrming the suspect of COPD; speciﬁc therapy
was started.
The patient gave an informed consent for the case report.
3. Discussion
Although nocardiosis is a rare disease, the clinical suspicion
even in immunocompetent patients and the microbiological
warning can lead to an early diagnosis and a life-saving treatment.
Our case represents a typical presentation of PN with clinical and
radiological ﬁndings mimicking TB.
3.1. Which patients should be suspected of PN?
Characteristics of PNmay be summarized as follows. The disease
is more common among males (73%) [20,41]. The mean age is 66
years, even if it can be higher in COPD cases or lower among organ
transplant recipients and patients with HIV or pulmonary alveolar
proteinosis [4,44]. As already mentioned in Section 1, symptoms of
PN are far from being speciﬁc. Among the laboratory tests,
neutrophilic leukocytosis and elevated C-reactive protein levels are
commonly seen in patients without HIV infection, leukopenia in
patients with HIV infection [5,20,42,45].
3.2. Which is the radiological presentation of PN?
As alreadymentioned in Section 1, radiographic ﬁndings are also
non pathognomonic. Very scanty information is available in the
literature about PN on HRCT. The predominant presentation is a
bilateral involvement with areas of consolidations, sometimes
associated with cavitations; nodules with or without cavitation are
most common in HIV-infected patients [46e50]. According to two
recent reviews, other ﬁndings may include masses, bronchial wall
and septal line thickening, bronchiectasis, ground glass opacity and
a crazy paving appearance around the previous lesions which are in
general more common in middle rather than peripheral areas;
intrathoracic lymphadenopathy, pleural effusion and pericardial
effusion have also been described [22,51].
3.3. How can the clinical and radiological suspect of PN be
conﬁrmed?
The diagnosis of PN requires isolation and identiﬁcation of the
organism from a clinical samples: sputum, tracheal aspiration or
bronchoalveolar lavage. Sputum samples can be diagnostic in
77e90% patients. The physician should inform the laboratory about
the suspect in order to increase the overall accuracy of the exam.
Specimen should ﬁrst be processed and stained for microscopy,
then cultured for at least 48e72 hours; typical stains include
modiﬁed acid-fast and Gram stains. When isolated, biochemical
Table 1
Case series of pulmonary nocardiosis in literature.
Author, year [Ref.] Pulmonary
nocardiosis
Any chronic
respiratory
disease
COPD COPD
GOLD IVa
Chronic
respiratory
disease other
than COPD
Maligniancies Diabetes Chronic
renal failure
Autoimmune
disease
Systemic steroid
therapy
Lacassagne et al.,
1996 [26]
3 3 2 2 2 e e e e 1
Mari et al., 2001
[45]
10 6 6 3 1(1) e e e 1 5(4)
Farina et al., 2002
[64]
18 10 5 e 5 2 e e e e
Pintado et al., 2002
[59]x
34 14 16 e 2 e 4 e e e
Saubolle and
Sussland, 2003
[65]
16 12 e e e e e e e e
Hui et al., 2003 [29] 35 22 10 e 19(7) 10(3) e e 2 20(8)
Matulionyte et al.,
2004 [60]
16 3 1 e e e e e e e
Mootsikapun et al.,
2005 [66]
31 3 1 e 2 e e e e e
Martinez-Tomas
et al., 2007 [4]
20 6 6 e 1(1) 1 e e 3 15(3)
Mun~oz et al., 2007
[41]
26 19 19 1 0 4(4) 2 e 5(3) 15(9)
Chedid et al., 2007
[13]
17 8 5 1 3 5(1) 2(1) e 3 12(2)
Tuo et al., 2008 [36] 21 11 8 e 3 e 2 e e 10
Tan et al., 2009 [67] 38 10 2 e 2 7(2) 6 5 7 11(1)
Valerio Minero
et al., 2009 [9]
26 11 8 e 3 3(1) e e 5(2) 19(6)
Maraki et al., 2009
[38]
2 2 2 e e e e e 1 1
Al-Jahdali et al.,
2011 [33]
25 13 13 e e e e e e e
Garcia-Bellmunt
et al., 2012 [42]
30 30 30 17 6 7 3 4 6 15
Chen YC et al., 2012
[68]
20 7 e e e 2 6 4 e 5
Hardak et al., 2012
[37]
32 11 3 e 8 e e e e e
Kurahara et al.,
2013 [20]
59 52 13 e 42 12 4 1 2 e
Yang et al., 2014
[69]
40 34 6 e e 5 13 4 8 20
Chen J et al., 2014
[70]
e 17 4 e e 2 e 3 3 11
Maggiorelli et al.
2014 [35]
4 3 3 2 3 e e e e 2
Aggarwal et al.,
2015 [27]
3 3 3 e 1 e e e e 2
Singh et al., 2015
[28]
4 3 2 1 3(1) 2 e e e 2(1)
Notes: Number patients with concomitant COPD is reported in brackets.
a According to Guideline GOLD 2010.
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tional phenotypes can be used for the rapid identiﬁcation of the
most common Nocardia spp. [52]. Molecular techniques (poly-
merase chain reaction, restriction enzyme, 16S rRNA gene
sequencing) are also available, even if restricted to referral labo-
ratories. In patients intolerant to sulfonamides, in severe cases and
in refractory cases, an antimicrobial susceptibility testing should be
performed [4,28,53].3.4. Differential diagnosis
TB, Pneumonia, carcinoma or abscessus are the most common
diseases with a similar presentation.Based on clinical and imaging ﬁndings, fungal infections
(aspergillosis, zigomycosis, hystoplasmosis, blastomycosis, cryp-
tococcosis), bacterial infections (mycobacterial infections, acti-
nomycosis and Rhodococcus equi infections) and malignancies
(primary and secondary lung cancer) should all be considered in
differential diagnosis of PN. Based on HRCT, pulmonary abscess,
septic emboli, sarcoidosis, Wegener granulomatosis should also
be taken into consideration when multiple nodules with cavita-
tion are present [14].
The most important differential diagnosis is Mycobacterial
infection, including Mycobacterium tuberculosis and non-
tuberculosis species. As already stated in Section 1, PN can mimic
TB because of both similar clinical presentation and radiological
Inhaled
steroids
Immunosuppressive
therapy other
than steroids
Immunosuppressive
therapy
(not speciﬁed)
Immunosuppressive
disease (HIV, …)
Co-infection Other
comorbidities
Immunosuppression
(not speciﬁed)
COPD e no
information
reported
COPD as
only risk
factor
e e e e e e e e e
e e e 3 e 1(1) e e 1
e e e 2 e 1 e 5 e
e e 8 8 e e e e e
e e e e e e e e e
e 9 21 3 5(2) e e e 1
1 e e e e e e e e
e e e e e e e 1 e
1(1) 8 e 3 e e e e e
e e e 3(1) e e e e e
e e e 1(1) e e 12 e 1
e 1 e e 9 2 e 8 e
e 4 e 1 e e e e e
e e e 4 1(1) e e e 1
e 1 e e e e e e e
e e e e e e e 13 e
e 7 e e e 2 7 e e
e e e e e 8 e e e
e e e e 3 e 17 e e
e e 2 e 26 e e e e
e 7 e 1 e e e e e
0 3 e 1 e e e e e
3 e e e e e e e e
1 e e e e e e e e
e e e e 4(2) e e e e
G. Castellana et al. / Respiratory Medicine Case Reports 18 (2016) 14e2118ﬁndings; this can easily lead to an initial unconﬁrmed diagnosis of
TB. Cases of concurrent PN and TB especially in HIV-infected pa-
tients are also reported in literature. According to some case series,
more than two thirds of PN cases were initially misdiagnosed with
TB and about 5% of the patients with proven pulmonary TB were
shown to be co-infected by Nocardia spp [11,12,35,45,54e60].
Concurrent infection of PN andMycobacterium avium-intracellulare
complex and PN and aspergillosis have also been reported
[29,61,62].3.5. Is truly COPD an isolated risk factor for PN?
The main characteristics of PN case series and PN single case in
COPD reported in literature are listed in Table 1 and Table 2,respectively. A signiﬁcant association between PN and COPD is
evident, but the analysis of case series and case reports shows that
many patients have a severe COPD with respiratory failure and/or
other comorbidies and coinfections.
In particular, it has been argued that COPD patients generally
receive chronic systemic and/or inhaled steroid [35], which could
be confounding when considering lung disease as the only risk
factor; this is considered to be true at least in two COPD pheno-
types: COPD with frequent exacerbations and COPD with presence
of bronchiectasis.
Four patients - one per each of the following case series: Valerio
Minero et al. [9], Chedid et al. [13], Hui et al. [29], Mari et al. [45] -
had no comorbidities and did not undergone systemic steroid
treatment; but no additional information on spirometry and
Table 2
Case reports of pulmonary nocardiosis in COPD in literature.
Shading used to divide the features analysed.
G. Castellana et al. / Respiratory Medicine Case Reports 18 (2016) 14e21 19chronic inhaled steroid therapy was reported on those patients and
no emphasis was given to the COPD as only risk factor. The only
clinical casewith features similar to our patient is the one described
by Riviere et al. [23]: given that the patient had never undergone a
chronic oral and/or inhaled steroid therapy, the Authors questioned
themselves whether COPD could represent a single risk factor for
PN. However, their patient had suffered from bronchiectasis after
pulmonary tuberculosis many years before.
However, as noted by some Authors, this confounding factors is
usually brief and doesn't cause a signiﬁcant impairment of cellular
immune responses: the review of Stuck et al. shows that patients
administered with <10 mg/day or a cumulative dose of <700 mg of
prednisone have similar infectious rates of the general population
[34]. Apart from the possible use of steroids, patients with COPD
may have an increased susceptibility to bacterial and fungal in-
fections for several reasons, such as a change in bronchial archi-
tecture, mucociliary dysfunction, epithelial damage, frequent
hospitalization or antibiotic treatments, and comorbidities
[4,23,63]. Moreover, in some case in immunocompetent patients
genetic factors could play a role in determining susceptibility to
infection [23].
4. Conclusions
PN is an infrequent but challenging diseasewhich should always
be considered both in immunocompromised and immunocompe-
tent patients. Symptoms, signs and imaging features (chest X-ray,
HRCT) can mimic other diseases, in particular TB, therefore a high
order of suspicion is crucial for a promptmicrobiological evaluation
and a life-saving treatment.
COPD is commonly considered a risk factor for PN. The reported
case - COPD patient with no respiratory failure, never treated with
systemic and inhaled steroid therapy and without comorbidieseis
an exemplary case for having COPD as the only risk factor for PN.
Whether COPD on its own is able to promote PN is still unclear and
requires further assessment.
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